• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Plasma Lp(a) and t-PA-PAI-1 complex levels in coronary heart disease.

作者信息

Süer S, Ulutin T, Sönmez H, Kökoğlu E, Uçişik N, Bayram C, Sultuybek G

机构信息

Department of Biochemistry, Istanbul University, Cerrahpaşa Medical Faculty, Turkey.

出版信息

Thromb Res. 1996 Jul 1;83(1):77-85. doi: 10.1016/0049-3848(96)00105-3.

DOI:10.1016/0049-3848(96)00105-3
PMID:8837306
Abstract

In this study we investigated serum Lp(a) and plasma t-PA-PAI-1 complex levels in patients with coronary heart disease (CHD). Serum total cholesterol, triglyceride, LDL and VDL cholesterol levels (p < 0.001) and HDL cholesterol levels (p < 0.01) in patients group were found to be significantly different from those in control group. The mean Lp(a) and t-PA-PAI-1 complex levels in patients with coronary heart disease were significantly higher as compared to control group (p < 0.001). This data indicate that the elevated levels of serum Lp(a) and plasma t-PA-PAI-1 complex may play an important role in the pathogenesis of coronary atherosclerosis.

摘要

相似文献

1
Plasma Lp(a) and t-PA-PAI-1 complex levels in coronary heart disease.
Thromb Res. 1996 Jul 1;83(1):77-85. doi: 10.1016/0049-3848(96)00105-3.
2
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.纤维蛋白原、凝血因子VII、组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂-1以及脂质作为慢性血液透析和持续性非卧床腹膜透析患者的心血管危险因素。
Am J Kidney Dis. 1996 Jun;27(6):848-54. doi: 10.1016/s0272-6386(96)90523-5.
3
Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.科威特高脂血症患者的脂蛋白(a)、组织纤溶酶原激活物和纤溶酶原激活物抑制剂1水平
Eur J Clin Invest. 1997 May;27(5):380-6. doi: 10.1046/j.1365-2362.1997.1230671.x.
4
Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.心脏移植受者血浆组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1水平与移植冠状动脉疾病的存在相关。
Am J Cardiol. 1997 Jul 15;80(2):145-9. doi: 10.1016/s0002-9149(97)00308-1.
5
Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.激素替代疗法对绝经后终末期肾病患者脂质及止血因子的影响。
Nephrol Dial Transplant. 2000 Nov;15(11):1835-40. doi: 10.1093/ndt/15.11.1835.
6
High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.冠心病患者中纤溶酶原激活物抑制物活性较高,与甘油三酯和高密度脂蛋白胆固醇值相关,心肌梗死幸存者之间无差异。
Ann Hematol. 1993 Nov;67(5):237-44. doi: 10.1007/BF01715054.
7
Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores.六种分馏血清脂蛋白的胆固醇水平及其与冠心病风险评分的相关性。
J Atheroscler Thromb. 2017 Sep 1;24(9):928-939. doi: 10.5551/jat.34728. Epub 2016 Dec 26.
8
The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations.通过双相琼脂糖凝胶电泳检测到的极低密度脂蛋白(VLDL)和低密度脂蛋白(LDL)之间的脂蛋白部分反映了血清残留脂蛋白和脂蛋白(a)[Lp(a)]的浓度。
J Atheroscler Thromb. 2006 Feb;13(1):55-61. doi: 10.5551/jat.13.55.
9
Association between incidence of lipoprotein(a) positivity and coronary heart disease.脂蛋白(a)阳性发生率与冠心病之间的关联。
Indian Heart J. 1992 Jul-Aug;44(4):223-6.
10
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.血脂异常中,凝血因子VIIc水平与组织因子途径抑制物降低及纤溶酶原激活物抑制物-1升高相关。
Arterioscler Thromb Vasc Biol. 1996 Jan;16(1):77-81. doi: 10.1161/01.atv.16.1.77.

引用本文的文献

1
Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease.冠状动脉粥样硬化患者的血浆玻连蛋白水平升高,且与疾病程度相关。
J Thromb Thrombolysis. 2002 Dec;14(3):221-5. doi: 10.1023/a:1025000810466.